Skip Navigation

Annals of Oncology Advance Access

Annals of Oncology Advance Access articles are papers that have been copyedited and typeset but not yet paginated for inclusion in an issue of the journal. More information, including how to cite Advance Access papers, can be found on the Advance Access page.

Advance Access Articles By Category [View by Date]

Go to section LETTER TO THE EDITORLETTER TO THE EDITOR
Go to section ORIGINAL ARTICLEORIGINAL ARTICLE
Go to section REVIEWREVIEW
Go to section EDITORIALEDITORIAL

To see an article, click its [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

LETTER TO THE EDITORGo to top of the page

letter to the editor
M. Mego, Z. Sycova-Mila, K. Rejlekova, B. Rychly, J. Obertova, J. Rajec, O. Hes, and J. Mardiak
Sunitinib in the treatment of tubulocystic carcinoma of the kidney. A case report
Annals of Oncology Advance Access published on July 8, 2008.
doi:10.1093/annonc/mdn408
[Extract] [Full Text] [PDF] [Request Permissions]  

letter to the editor
S. Cowman, J. Stebbing, and M. Tuthill
Large bowel perforation associated with capecitabine treatment for breast cancer
Annals of Oncology Advance Access published on June 18, 2008.
doi:10.1093/annonc/mdn397
[Extract] [Full Text] [PDF] [Request Permissions]  

letter to the editor
H. A. Azim Jr, F. A. Peccatori, G. Scarfone, B. Acaia, P. Rossi, R. Cascio, and A. Goldhirsch
Anthracyclines for gestational breast cancer: course and outcome of pregnancy
Annals of Oncology Advance Access published on June 18, 2008.
doi:10.1093/annonc/mdn396
[Extract] [Full Text] [PDF] [Request Permissions]  

letter to the editor
A. Ring, R. Simcock, S. Mitra, D. Bloomfield, J. King, S. Simpson, G. Sadler, and A. Webb
Infusion of trastuzumab maintenance doses over 30 minutes
Annals of Oncology Advance Access published on June 6, 2008.
doi:10.1093/annonc/mdn390
[Extract] [Full Text] [PDF] [Request Permissions]  

letter to the editor
A. Necchi, N. Nicolai, and R. Salvioni
Does oxaliplatin and paclitaxel combination show an activity of some extent in pretreated patients with germ-cell tumors?: Reply to the article "A phase II multicenter study of oxaliplatin in combination with paclitaxel in poor prognosis patients who failed cisplatin-based chemotherapy for germ-cell tumors" by C. Theodore et al. (Ann Oncol 2008; doi: 10.1093/annonc/mdn122)
Annals of Oncology Advance Access published on May 25, 2008.
doi:10.1093/annonc/mdn371
[Extract] [Full Text] [PDF] [Request Permissions]  

ORIGINAL ARTICLEGo to top of the page

original article
L. J. Hoffer, M. Levine, S. Assouline, D. Melnychuk, S. J. Padayatty, K. Rosadiuk, C. Rousseau, L. Robitaille, and W. H. Miller Jr
Phase I clinical trial of i.v. ascorbic acid in advanced malignancy
Annals of Oncology Advance Access published on June 25, 2008.
doi:10.1093/annonc/mdn377
[Abstract] [Full Text] [PDF] [Request Permissions]  

original article
D. Ennishi, K. Takeuchi, M. Yokoyama, H. Asai, Y. Mishima, Y. Terui, S. Takahashi, H. Komatsu, K. Ikeda, M. Yamaguchi, R. Suzuki, M. Tanimoto, and K. Hatake
CD5 expression is potentially predictive of poor outcome among biomarkers in patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP therapy
Annals of Oncology Advance Access published on June 23, 2008.
doi:10.1093/annonc/mdn392
[Abstract] [Full Text] [PDF] [Request Permissions]  

original article
B. Sirohi, M. Arnedos, S. Popat, S. Ashley, A. Nerurkar, G. Walsh, S. Johnston, and I. E. Smith
Platinum-based chemotherapy in triple-negative breast cancer
Annals of Oncology Advance Access published on June 20, 2008.
doi:10.1093/annonc/mdn395
[Abstract] [Full Text] [PDF] [Request Permissions]  

original article
S. H. Ghaffari, N. Shayan-Asl, A. H. Jamialahmadi, K. Alimoghaddam, and A. Ghavamzadeh
Telomerase activity and telomere length in patients with acute promyelocytic leukemia: indicative of proliferative activity, disease progression, and overall survival
Annals of Oncology Advance Access published on June 20, 2008.
doi:10.1093/annonc/mdn394
[Abstract] [Full Text] [PDF] [Request Permissions]  

original article
B. C. Pestalozzi, P. Francis, E. Quinaux, S. Dolci, E. Azambuja, R. D. Gelber, G. Viale, A. Balil, M. Andersson, B. Nordenskjöld, M. Gnant, J. Gutierrez, I. Láng, J. P. A. Crown, M. Piccart-Gebhart, and On behalf of the BIG 02-98 Collaborative Group
Is risk of central nervous system (CNS) relapse related to adjuvant taxane treatment in node-positive breast cancer? Results of the CNS substudy in the intergroup phase III BIG 02-98 trial
Annals of Oncology Advance Access published on June 18, 2008.
doi:10.1093/annonc/mdn385
[Abstract] [Full Text] [PDF] [Request Permissions]  

original article
M. Sieniawski, T. Reineke, A. Josting, L. Nogova, K. Behringer, T. Halbsguth, M. Fuchs, V. Diehl, and A. Engert
Assessment of male fertility in patients with Hodgkin's lymphoma treated in the German Hodgkin Study Group (GHSG) clinical trials
Annals of Oncology Advance Access published on June 17, 2008.
doi:10.1093/annonc/mdn376
[Abstract] [Full Text] [PDF] [Request Permissions]  

original article
N. Termine, V. Panzarella, S. Falaschini, A. Russo, D. Matranga, L. Lo Muzio, and G. Campisi
HPV in oral squamous cell carcinoma vs head and neck squamous cell carcinoma biopsies: a meta-analysis (1988–2007)
Annals of Oncology Advance Access published on June 16, 2008.
doi:10.1093/annonc/mdn372
[Abstract] [Full Text] [PDF] [Request Permissions]  

original article
M. Dank, J. Zaluski, C. Barone, V. Valvere, S. Yalcin, C. Peschel, M. Wenczl, E. Goker, L. Cisar, K. Wang, and R. Bugat
Randomized phase III study comparing irinotecan combined with 5-fluorouracil and folinic acid to cisplatin combined with 5-fluorouracil in chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction
Annals of Oncology Advance Access published on June 16, 2008.
doi:10.1093/annonc/mdn166
[Abstract] [Full Text] [PDF] [Request Permissions]  

original article
I. Biasoli, P. Franchi-Rezgui, D. Sibon, J. Brière, E. de Kerviler, C. Thieblemont, V. Levy, C. Gisselbrecht, and P. Brice
Analysis of factors influencing inclusion of 102 patients with stage III/IV Hodgkin's lymphoma in a randomized trial for first-line chemotherapy
Annals of Oncology Advance Access published on June 13, 2008.
doi:10.1093/annonc/mdn391
[Abstract] [Full Text] [PDF] [Request Permissions]  

original article
J. Emmering, N. C. Krak, J. J. M. Van der Hoeven, M. D. Spreeuwenberg, J. W. R. Twisk, S. Meijer, H. M. Pinedo, and O. S. Hoekstra
Preoperative [18F] FDG–PET after chemotherapy in locally advanced breast cancer: prognostic value as compared with histopathology
Annals of Oncology Advance Access published on June 13, 2008.
doi:10.1093/annonc/mdn185
[Abstract] [Full Text] [PDF] [Request Permissions]  

original article
C. Catania, V. Zagonel, V. Fosser, N. La Verde, O. Bertetto, C. Iacono, M. Venturini, D. Radice, L. Adamoli, and F. Boccardo
Opinions concerning euthanasia, life-sustaining treatment and acceleration of death: results of an Italian Association of Medical Oncology (AIOM) survey
Annals of Oncology Advance Access published on June 12, 2008.
doi:10.1093/annonc/mdn381
[PDF] [Request Permissions]  

original article
G. Lurje, W. Zhang, A. M. Schultheis, D. Yang, S. Groshen, A. E. Hendifar, H. Husain, M. A. Gordon, F. Nagashima, H. M. Chang, and H.-J. Lenz
Polymorphisms in VEGF and IL-8 predict tumor recurrence in stage III colon cancer
Annals of Oncology Advance Access published on June 11, 2008.
doi:10.1093/annonc/mdn368
[Abstract] [Full Text] [PDF] [Request Permissions]  

original article
P. Poletti, P. Fenaroli, A. Milesi, A. Paludetti, S. Mangiarotti, G. Virotta, E. Candiago, A. Bettini, E. R. Caremoli, R. Labianca, and C. Tondini
Axillary recurrence in sentinel lymph node-negative breast cancer patients
Annals of Oncology Advance Access published on June 10, 2008.
doi:10.1093/annonc/mdn393
[Abstract] [Full Text] [PDF] [Request Permissions]  

original article
M. E. Lacouture, L. M. Reilly, P. Gerami, and J. Guitart
Hand foot skin reaction in cancer patients treated with the multikinase inhibitors sorafenib and sunitinib
Annals of Oncology Advance Access published on June 10, 2008.
doi:10.1093/annonc/mdn389
[Abstract] [Full Text] [PDF] [Request Permissions]  

original article
M. L. Rothenberg, J. V. Cox, C. Butts, M. Navarro, Y.-J. Bang, R. Goel, S. Gollins, L. L. Siu, S. Laguerre, and D. Cunningham
Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority study
Annals of Oncology Advance Access published on June 10, 2008.
doi:10.1093/annonc/mdn370
[Abstract] [Full Text] [PDF] [Request Permissions]  

original article
R. L. Elstrom, J. P. Leonard, M. Coleman, and R. K. J. Brown
Combined PET and low-dose, noncontrast CT scanning obviates the need for additional diagnostic contrast-enhanced CT scans in patients undergoing staging or restaging for lymphoma
Annals of Oncology Advance Access published on June 10, 2008.
doi:10.1093/annonc/mdn282
[Abstract] [Full Text] [PDF] [Request Permissions]  

original article
F. Tas
The contribution of countries and world regions in productivity of oncological publication
Annals of Oncology Advance Access published on June 9, 2008.
doi:10.1093/annonc/mdn378
[Abstract] [Full Text] [PDF] [Request Permissions]  

original article
S. Ménard, A. Balsari, E. Tagliabue, T. Camerini, P. Casalini, R. Bufalino, F. Castiglioni, M. L. Carcangiu, A. Gloghini, S. Scalone, P. Querzoli, M. Lunardi, A. Molino, M. Mandarà, M. Mottolese, F. Marandino, M. Venturini, C. Bighin, G. Cancello, E. Montagna, F. Perrone, A. De Matteis, A. Sapino, M. Donadio, N. Battelli, A. Santinelli, L. Pavesi, A. Lanza, F. A. Zito, A. Labriola, R. A. Aiello, M. Caruso, F. Zanconati, G. Mustacchi, M. Barbareschi, M. Frisinghelli, R. Russo, G. Carrillo, and On the behalf of the OMERO group
Biology, prognosis and response to therapy of breast carcinomas according to HER2 score
Annals of Oncology Advance Access published on June 9, 2008.
doi:10.1093/annonc/mdn369
[Abstract] [Full Text] [PDF] [Supplementary Data] [Request Permissions]  

original article
K. Amara, M. Trimeche, S. Ziadi, A. Laatiri, M. Hachana, and S. Korbi
Prognostic significance of aberrant promoter hypermethylation of CpG islands in patients with diffuse large B-cell lymphomas
Annals of Oncology Advance Access published on June 6, 2008.
doi:10.1093/annonc/mdn374
[Abstract] [Full Text] [PDF] [Request Permissions]  

original article
J. K. Salama, K. M. Stenson, E. O. Kistner, B. B. Mittal, A. Argiris, M. E. Witt, F. Rosen, B. E. Brockstein, E. E. W. Cohen, D. J. Haraf, and E. E. Vokes
Induction chemotherapy and concurrent chemoradiotherapy for locoregionally advanced head and neck cancer: a multi-institutional phase II trial investigating three radiotherapy dose levels
Annals of Oncology Advance Access published on June 6, 2008.
doi:10.1093/annonc/mdn364
[Abstract] [Full Text] [PDF] [Request Permissions]  

original article
S. L. Hines, L. A. Vallow, W. W. Tan, R. B. McNeil, E. A. Perez, and A. Jain
Clinical outcomes after a diagnosis of brain metastases in patients with estrogen- and/or human epidermal growth factor receptor 2-positive versus triple-negative breast cancer
Annals of Oncology Advance Access published on June 5, 2008.
doi:10.1093/annonc/mdn283
[Abstract] [Full Text] [PDF] [Request Permissions]  

original article
B. R. Tan, W. S. Brenner, J. Picus, S. Marsh, F. Gao, C. Fournier, P. M. Fracasso, J. James, J. L. Yen-Revollo, and H. L. Mcleod
Phase I study of biweekly oxaliplatin, gemcitabine and capecitabine in patients with advanced upper gastrointestinal malignancies
Annals of Oncology Advance Access published on June 4, 2008.
doi:10.1093/annonc/mdn375
[Abstract] [Full Text] [PDF] [Request Permissions]  

original article
M. J. Bishton, M. F. Leahy, R. J. Hicks, J. H. Turner, A. D. McQuillan, and J. F. Seymour
Repeat treatment with iodine-131-rituximab is safe and effective in patients with relapsed indolent B-cell non-Hodgkin's lymphoma who had previously responded to iodine-131-rituximab
Annals of Oncology Advance Access published on June 2, 2008.
doi:10.1093/annonc/mdn172
[Abstract] [Full Text] [PDF] [Request Permissions]  

Original Article
T. R. Halfdanarson, K. G. Rabe, J. Rubin, and G. M. Petersen
Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival
Annals of Oncology Advance Access published on May 30, 2008.
doi:10.1093/annonc/mdn351
[Abstract] [Full Text] [PDF] [Request Permissions]  

original article
M. Cristofanilli, P. Morandi, S. Krishnamurthy, J. M. Reuben, B.-N. Lee, D. Francis, D. J. Booser, M. C. Green, B. K. Arun, L. Pusztai, A. Lopez, R. Islam, V. Valero, and G. N. Hortobagyi
Imatinib mesylate (Gleevec®) in advanced breast cancer-expressing C-Kit or PDGFR-β: clinical activity and biological correlations
Annals of Oncology Advance Access published on May 29, 2008.
doi:10.1093/annonc/mdn352
[Abstract] [Full Text] [PDF] [Request Permissions]  

original article
J. H. Mendler, J. Kelly, S. Voci, D. Marquis, L. Rich, R. M. Rossi, S. H. Bernstein, C. T. Jordan, J. Liesveld, R. I. Fisher, and J. W. Friedberg
Bortezomib and gemcitabine in relapsed or refractory Hodgkin's lymphoma
Annals of Oncology Advance Access published on May 25, 2008.
doi:10.1093/annonc/mdn365
[Abstract] [Full Text] [PDF] [Request Permissions]  

original article
J. P. Sculier, J. J. Lafitte, A. Efremidis, M. C. Florin, J. Lecomte, M. C. Berchier, M. Richez, T. Berghmans, A. Scherpereel, A. P. Meert, G. Koumakis, N. Leclercq, M. Paesmans, P. Van Houtte, and for the European Lung Cancer Working Party (ELCWP)
A phase III randomised study of concomitant induction radiochemotherapy testing two modalities of radiosensitisation by cisplatin (standard versus daily) for limited small-cell lung cancer
Annals of Oncology Advance Access published on May 25, 2008.
doi:10.1093/annonc/mdn354
[Abstract] [Full Text] [PDF] [Request Permissions]  

original article
P. M. McGowan and M. J. Duffy
Matrix metalloproteinase expression and outcome in patients with breast cancer: analysis of a published database
Annals of Oncology Advance Access published on May 23, 2008.
doi:10.1093/annonc/mdn180
[Abstract] [Full Text] [PDF] [Request Permissions]  

original article
M. von Mehren, R. J. Schilder, J. D. Cheng, E. Temmer, T. M. Cardoso, F. G. Renshaw, E. Bayever, P. Zannikos, Z. Yuan, and R. B. Cohen
A phase I study of the safety and pharmacokinetics of trabectedin in combination with pegylated liposomal doxorubicin in patients with advanced malignancies
Annals of Oncology Advance Access published on May 22, 2008.
doi:10.1093/annonc/mdn363
[Abstract] [Full Text] [PDF] [Request Permissions]  

original article
D. R. Berthold, G. R. Pond, R. de Wit, M. Eisenberger, I. F. Tannock, and On behalf of the TAX 327 investigators
Survival and PSA response of patients in the TAX 327 study who crossed over to receive docetaxel after mitoxantrone or vice versa
Annals of Oncology Advance Access published on May 16, 2008.
doi:10.1093/annonc/mdn288
[Abstract] [Full Text] [PDF] [Request Permissions]  

original article
M. de Wit, W. Brenner, M. Hartmann, J. Kotzerke, D. Hellwig, J. Lehmann, C. Franzius, S. Kliesch, M. Schlemmer, K. Tatsch, R. Heicappell, L. Geworski, H. Amthauer, B. M. Dohmen, H. Schirrmeister, U. Cremerius, C. Bokemeyer, and R. Bares
[18F]-FDG–PET in clinical stage I/II non-seminomatous germ cell tumours: results of the German multicentre trial
Annals of Oncology Advance Access published on May 16, 2008.
doi:10.1093/annonc/mdn170
[Abstract] [Full Text] [PDF] [Request Permissions]  

original article
C. Lafaras, E. Mandala, E. Verrou, D. Platogiannis, N. Barbetakis, T. Bischiniotis, and K. Zervas
Nonthromboembolic pulmonary hypertension in multiple myeloma, after thalidomide treatment: A pilot study
Annals of Oncology Advance Access published on May 13, 2008.
doi:10.1093/annonc/mdn287
[Abstract] [Full Text] [PDF] [Request Permissions]  

original article
J. Rom, G. von Minckwitz, W. Eiermann, M. Sievert, B. Schlehe, F. Marmé, F. Schuetz, A. Scharf, M. Eichbaum, H.-P. Sinn, M. Kaufmann, C. Sohn, and A. Schneeweiss
Oblimersen combined with docetaxel, adriamycin and cyclophosphamide as neo-adjuvant systemic treatment in primary breast cancer: final results of a multicentric phase I study
Annals of Oncology Advance Access published on May 13, 2008.
doi:10.1093/annonc/mdn280
[Abstract] [Full Text] [PDF] [Request Permissions]  

original article
A. K. Ng, S. Li, D. Neuberg, R. Chi, D. C. Fisher, B. Silver, and P. M. Mauch
A prospective study of pulmonary function in Hodgkin’s lymphoma patients
Annals of Oncology Advance Access published on May 7, 2008.
doi:10.1093/annonc/mdn284
[Abstract] [Full Text] [PDF] [Request Permissions]  

original article
B. Chauffert, F. Mornex, F. Bonnetain, P. Rougier, C. Mariette, O. Bouché, J. F. Bosset, T. Aparicio, L. Mineur, A. Azzedine, P. Hammel, J. Butel, N. Stremsdoerfer, P. Maingon, and L. Bedenne
Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000–01 FFCD/SFRO study
Annals of Oncology Advance Access published on May 7, 2008.
doi:10.1093/annonc/mdn281
[Abstract] [Full Text] [PDF] [Request Permissions]  

original article
P. A. Zucali, M. G. Ruiz, E. Giovannetti, A. Destro, M. Varella-Garcia, K. Floor, G. L. Ceresoli, J. A. Rodriguez, I. Garassino, P. Comoglio, M. Roncalli, A. Santoro, and G. Giaccone
Role of cMET expression in non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitors
Annals of Oncology Advance Access published on May 7, 2008.
doi:10.1093/annonc/mdn240
[Abstract] [Full Text] [PDF] [Request Permissions]  

original article
U. Veronesi, P. Arnone, P. Veronesi, V. Galimberti, A. Luini, N. Rotmensz, E. Botteri, G. B. Ivaldi, M. C. Leonardi, G. Viale, A. Sagona, G. Paganelli, R. Panzeri, and R. Orecchia
The value of radiotherapy on metastatic internal mammary nodes in breast cancer. Results on a large series
Annals of Oncology Advance Access published on May 7, 2008.
doi:10.1093/annonc/mdn183
[Abstract] [Full Text] [PDF] [Request Permissions]  

original article
R. Shivakumar, W. Tan, G. E. Wilding, E. S. Wang, and M. Wetzler
Biologic features and treatment outcome of secondary acute lymphoblastic leukemia—a review of 101 cases
Annals of Oncology Advance Access published on May 7, 2008.
doi:10.1093/annonc/mdn182
[Abstract] [Full Text] [PDF] [Supplementary Data] [Request Permissions]  

original article
D. E. Heron, A. Brufsky, S. Beriwal, and M. Kurman
Myelotoxicity of samarium Sm 153 lexidronam in patients receiving prior treatment with chemotherapy or radiotherapy
Annals of Oncology Advance Access published on May 7, 2008.
doi:10.1093/annonc/mdn178
[Abstract] [Full Text] [PDF] [Request Permissions]  

original article
H. J. Meulenbeld, L. N. van Steenbergen, M. L. G. Janssen-Heijnen, V. E. P. P. Lemmens, and G. J. Creemers
Significant improvement in survival of patients presenting with metastatic colon cancer in the south of The Netherlands from 1990 to 2004
Annals of Oncology Advance Access published on May 7, 2008.
doi:10.1093/annonc/mdn176
[Abstract] [Full Text] [PDF] [Request Permissions]  

original article
G. Gravis, F. Bladou, N. Salem, A. Gonçalves, B. Esterni, J. Walz, S. Bagattini, M. Marcy, S. Brunelle, and P. Viens
Results from a monocentric phase II trial of erlotinib in patients with metastatic prostate cancer
Annals of Oncology Advance Access published on May 7, 2008.
doi:10.1093/annonc/mdn174
[Abstract] [Full Text] [PDF] [Request Permissions]  

original article
B. R. Knab, J. K. Salama, A. Solanki, K. M. Stenson, E. E. Cohen, M. E. Witt, D. J. Haraf, and E. E. Vokes
Functional organ preservation with definitive chemoradiotherapy for T4 laryngeal squamous cell carcinoma
Annals of Oncology Advance Access published on May 7, 2008.
doi:10.1093/annonc/mdn173
[Abstract] [Full Text] [PDF] [Request Permissions]  

Original Article
J. Wang, D. Short, N. J. Sebire, I. Lindsay, E. S. Newlands, P. Schmid, P. M. Savage, and M. J. Seckl
Salvage chemotherapy of relapsed or high-risk gestational trophoblastic neoplasia (GTN) with paclitaxel/cisplatin alternating with paclitaxel/etoposide (TP/TE)
Annals of Oncology Advance Access published on May 2, 2008.
doi:10.1093/annonc/mdn181
[Abstract] [Full Text] [PDF] [Request Permissions]  

Original Article
E. Schmidt, N. H. Thoennissen, A. Rudat, R. Bieker, C. Schliemann, R. M. Mesters, M. Zühlsdorf, C. Müller-Tidow, and W. E. Berdel
Use of palifermin for the prevention of high-dose methotrexate-induced oral mucositis
Annals of Oncology Advance Access published on May 2, 2008.
doi:10.1093/annonc/mdn179
[Abstract] [Full Text] [PDF] [Request Permissions]  

original article
P. Hadji, J.-J. Body, M. S. Aapro, A. Brufsky, R. E. Coleman, T. Guise, A. Lipton, and M. Tubiana-Hulin
Practical guidance for the management of aromatase inhibitor-associated bone loss
Annals of Oncology Advance Access published on April 29, 2008.
doi:10.1093/annonc/mdn164
[Abstract] [Full Text] [PDF] [Request Permissions]  

original article
F. Puglisi, G. G. Cardellino, D. Crivellari, C. Di Loreto, M. D. Magri, A. M. Minisini, M. Mansutti, C. Andreetta, S. Russo, D. Lombardi, T. Perin, G. Damante, and A. Veronesi
Thymidine phosphorylase expression is associated with time to progression in patients receiving low-dose, docetaxel-modulated capecitabine for metastatic breast cancer
Annals of Oncology Advance Access published on April 25, 2008.
doi:10.1093/annonc/mdn165
[Abstract] [Full Text] [PDF] [Request Permissions]  

original article
D. Arnold, T. Höhler, C. Dittrich, F. Lordick, T. Seufferlein, J. Riemann, E. Wöll, T. Herrmann, A. Zubel, and H.-J. Schmoll
Cetuximab in combination with weekly 5-fluorouracil/folinic acid and oxaliplatin (FUFOX) in untreated patients with advanced colorectal cancer: a phase Ib/II study of the AIO GI Group
Annals of Oncology Advance Access published on April 25, 2008.
doi:10.1093/annonc/mdn150
[Abstract] [Full Text] [PDF] [Supplementary Data] [Request Permissions]  

original article
X. Pivot, P. Koralewski, J. L. Hidalgo, A. Chan, A. Gonçalves, G. Schwartsmann, S. Assadourian, and J. P. Lotz
A multicenter phase II study of XRP6258 administered as a 1-h i.v. infusion every 3 weeks in taxane-resistant metastatic breast cancer patients
Annals of Oncology Advance Access published on April 23, 2008.
doi:10.1093/annonc/mdn171
[Abstract] [Full Text] [PDF] [Request Permissions]  

original article
M. L. Telli, R. M. Witteles, G. A. Fisher, and S. Srinivas
Cardiotoxicity associated with the cancer therapeutic agent sunitinib malate
Annals of Oncology Advance Access published on April 23, 2008.
doi:10.1093/annonc/mdn168
[Abstract] [Full Text] [PDF] [Request Permissions]  

original article
Q. Zhong, Y.-J. Wen, H.-S. Yang, H. Luo, A.-F. Fu, F. Yang, L.-J. Chen, X. Chen, X.-R. Qi, H.-G. Lin, Y. Wan, X.-C. Chen, Y.-Q. Wei, and X. Zhao
Efficient inhibition of cisplatin-resistant human ovarian cancer growth and prolonged survival by gene transferred vesicular stomatitis virus matrix protein in nude mice
Annals of Oncology Advance Access published on April 23, 2008.
doi:10.1093/annonc/mdn167
[Abstract] [Full Text] [PDF] [Request Permissions]  

original article
M. Zoubir, M. C. Mathieu, C. Mazouni, C. Liedtke, L. Corley, S. Geha, J. Bouaziz, M. Spielmann, F. Drusche, W. F. Symmans, S. Delaloge, and F. Andre
Modulation of ER phosphorylation on serine 118 by endocrine therapy: a new surrogate marker for efficacy
Annals of Oncology Advance Access published on April 23, 2008.
doi:10.1093/annonc/mdn151
[Abstract] [Full Text] [PDF] [Request Permissions]  

original article
G. Cartron, M. Ohresser, G. Salles, P. Solal-Céligny, P. Colombat, and H. Watier
Neutrophil role in in vivo anti-lymphoma activity of rituximab: FCGR3B-NA1/NA2 polymorphism does not influence response and survival after rituximab treatment
Annals of Oncology Advance Access published on April 11, 2008.
doi:10.1093/annonc/mdn163
[Abstract] [Full Text] [PDF] [Request Permissions]  

original article
T. de La Motte Rouge, P. Pautier, P. Duvillard, A. Rey, P. Morice, C. Haie-Meder, P. Kerbrat, S. Culine, F. Troalen, and C. Lhommé
Survival and reproductive function of 52 women treated with surgery and bleomycin, etoposide, cisplatin (BEP) chemotherapy for ovarian yolk sac tumor
Annals of Oncology Advance Access published on April 11, 2008.
doi:10.1093/annonc/mdn162
[Abstract] [Full Text] [PDF] [Request Permissions]  

original article
B. Melichar, P. Koralewski, A. Ravaud, A. Pluzanska, S. Bracarda, C. Szczylik, C. Chevreau, M. Filipek, R. Delva, E. Sevin, S. Négrier, J. McKendrick, A. Santoro, P. Pisa, and B. Escudier
First-line bevacizumab combined with reduced dose interferon-{alpha}2a is active in patients with metastatic renal cell carcinoma
Annals of Oncology Advance Access published on April 11, 2008.
doi:10.1093/annonc/mdn161
[Abstract] [Full Text] [PDF] [Request Permissions]  

original article
Y. Xu, Y. Sun, L. Yao, L. Shi, Y. Wu, T. Ouyang, J. Li, T. Wang, Z. Fan, T. Fan, B. Lin, L. He, P. Li, and Y. Xie
Association between CYP2D6 *10 genotype and survival of breast cancer patients receiving tamoxifen treatment
Annals of Oncology Advance Access published on April 11, 2008.
doi:10.1093/annonc/mdn155
[Abstract] [Full Text] [PDF] [Request Permissions]  

original article
E. Mrozek, J. Kolesar, D. Young, J. Allen, M. Villalona-Calero, and C.L. Shapiro
Phase II study of sequentially administered low-dose mitomycin-C (MMC) and irinotecan (CPT-11) in women with metastatic breast cancer (MBC)
Annals of Oncology Advance Access published on April 11, 2008.
doi:10.1093/annonc/mdn154
[Abstract] [Full Text] [PDF] [Request Permissions]  

original article
J. Fernández-Delgado, M. J. López-Pedraza, J. A. Blasco, E. Andradas-Aragones, J. I. Sánchez-Méndez, G. Sordo-Miralles, and M. M. Reza
Satisfaction with and psychological impact of immediate and deferred breast reconstruction
Annals of Oncology Advance Access published on April 4, 2008.
doi:10.1093/annonc/mdn153
[Abstract] [Full Text] [PDF] [Request Permissions]  

original article
I. Scionti, F. Michelacci, M. Pasello, C. M. Hattinger, M. Alberghini, M. C. Manara, G. Bacci, S. Ferrari, K. Scotlandi, P. Picci, and Massimo Serra
Clinical impact of the methotrexate resistance-associated genes C-MYC and dihydrofolate reductase (DHFR) in high-grade osteosarcoma
Annals of Oncology Advance Access published on April 2, 2008.
doi:10.1093/annonc/mdn148
[Abstract] [Full Text] [PDF] [Supplementary Data] [Request Permissions]  

original article
T. M. Kim, S.-Y. Lee, Y. K. Jeon, B.-Y. Ryoo, G. J. Cho, Y. S. Hong, H. J. Kim, S.-Y. Kim, C. S. Kim, S. Kim, J. S. Kim, S. K. Sohn, H. H. Song, J. L. Lee, Y. K. Kang, C. Y. Yim, W. S. Lee, Y. J. Yuh, C. W. Kim, D. S. Heo, and for the Lymphoma Subcommittee of the Korean Cancer Study Group
Clinical heterogeneity of extranodal NK/T-cell lymphoma, nasal type: a national survey of the Korean Cancer Study Group
Annals of Oncology Advance Access published on April 2, 2008.
doi:10.1093/annonc/mdn147
[Abstract] [Full Text] [PDF] [Request Permissions]  

original article
G. Gruber, B. F. Cole, M. Castiglione-Gertsch, S. B. Holmberg, J. Lindtner, R. Golouh, J. Collins, D. Crivellari, B. Thürlimann, E. Simoncini, M. F. Fey, R. D. Gelber, A. S. Coates, K. N. Price, A. Goldhirsch, G. Viale, B. A. Gusterson, and for the International Breast Cancer Study Group
Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer
Annals of Oncology Advance Access published on April 2, 2008.
doi:10.1093/annonc/mdn123
[Abstract] [Full Text] [PDF] [Request Permissions]  

original article
C. Theodore, C. Chevreau, Y. Yataqhene, K. Fizazi, J.-P. Delord, J.-P. Lotz, L. Geoffrois, P. Kerbrat, V. Bui, and A. Flechon
A phase II multicenter study of oxaliplatin in combination with paclitaxel in poor prognosis patients who failed cisplatin-based chemotherapy for germ-cell tumors
Annals of Oncology Advance Access published on April 2, 2008.
doi:10.1093/annonc/mdn122
[Abstract] [Full Text] [PDF] [Request Permissions]  

original article
J. Bellmunt, C. Szczylik, J. Feingold, A. Strahs, and A. Berkenblit
Temsirolimus safety profile and management of toxic effects in patients with advanced renal cell carcinoma and poor prognostic features
Annals of Oncology Advance Access published on April 2, 2008.
doi:10.1093/annonc/mdn066
[Abstract] [Full Text] [PDF] [Request Permissions]  

original article
F. Dimeo, S. Schwartz, N. Wesel, A. Voigt, and E. Thiel
Effects of an endurance and resistance exercise program on persistent cancer-related fatigue after treatment
Annals of Oncology Advance Access published on April 1, 2008.
doi:10.1093/annonc/mdn068
[Abstract] [Full Text] [PDF] [Request Permissions]  

Original Article
W. Jacot, B. Colinet, D. Bertrand, S. Lacombe, M.-C. Bozonnat, J.-P. Daurès, J.-L. Pujol, and for the OncoLR health network
Quality of life and comorbidity score as prognostic determinants in non-small-cell lung cancer patients
Annals of Oncology Advance Access published on March 19, 2008.
doi:10.1093/annonc/mdn064
[Abstract] [Full Text] [PDF] [Request Permissions]  

Original Article
A. Tun-Kyi, J.-Z. Qin, P. A. Oberholzer, A. A. Navarini, J. C. Hassel, R. Dummer, and U. Döbbeling
Arsenic trioxide down-regulates antiapoptotic genes and induces cell death in mycosis fungoides tumors in a mouse model
Annals of Oncology Advance Access published on March 17, 2008.
doi:10.1093/annonc/mdn056
[Abstract] [Full Text] [PDF] [Request Permissions]  

REVIEWGo to top of the page

review
M. Hickey, C. Saunders, A. Partridge, N. Santoro, H. Joffe, and V. Stearns
Practical clinical guidelines for assessing and managing menopausal symptoms after breast cancer
Annals of Oncology Advance Access published on June 16, 2008.
doi:10.1093/annonc/mdn353
[Abstract] [Full Text] [PDF] [Request Permissions]  

review
R. Demicheli, M. W. Retsky, W. J. M. Hrushesky, M. Baum, and I. D. Gukas
The effects of surgery on tumor growth: a century of investigations
Annals of Oncology Advance Access published on June 10, 2008.
doi:10.1093/annonc/mdn386
[Abstract] [Full Text] [PDF] [Request Permissions]  

review
R. S. Finn
Targeting Src in breast cancer
Annals of Oncology Advance Access published on May 16, 2008.
doi:10.1093/annonc/mdn291
[Abstract] [Full Text] [PDF] [Request Permissions]  

review
D. Rayson, D. Richel, S. Chia, C. Jackisch, S. van der Vegt, and T. Suter
Anthracycline–trastuzumab regimens for HER2/neu-overexpressing breast cancer: current experience and future strategies
Annals of Oncology Advance Access published on May 13, 2008.
doi:10.1093/annonc/mdn292
[Abstract] [Full Text] [PDF] [Request Permissions]  

review
C. Gravalos and A. Jimeno
HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target
Annals of Oncology Advance Access published on April 25, 2008.
doi:10.1093/annonc/mdn169
[Abstract] [Full Text] [PDF] [Request Permissions]  

review
E. Casado, P. Pfeiffer, J. Feliu, M. González-Barón, L. Vestermark, and H. A. Jensen
UFT (tegafur–uracil) in rectal cancer
Annals of Oncology Advance Access published on April 1, 2008.
doi:10.1093/annonc/mdn067
[Abstract] [Full Text] [PDF] [Request Permissions]  

EDITORIALGo to top of the page

editorial
S. Négrier
Temsirolimus in metastatic renal cell carcinoma
Annals of Oncology Advance Access published on May 25, 2008.
doi:10.1093/annonc/mdn373
[Extract] [Full Text] [PDF] [Request Permissions]  

To see an article, click its [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.